貨號: |
BI-20852W |
方法學: |
Competitive EIA, HRP/TMB, 12x8-well strips |
樣本類型: |
Serum, plasma (EDTA, heparin, citrate) |
標準品範圍: |
0-6400 pmol/l (7 serum based standards) |
標準品濃度: |
0/200/400/800/1600/3200/6400 pmol/l |
質控品: |
1 serum based control |
樣本量: |
30 μl / well |
孵育時間: |
Overnight (18-25h) / 20 min |
單位換算: |
1 pg/ml = 0.118 pmol/l (MW: 8.475 kDa) |
靈敏度:
LOD: 171 pmol/l at 95% B/B0
精密度
:
Intra-assay (n=3) ≤ 8%, Inter-assay (n=8) ≤ 7%
回收率
:
The mean recovery of recombinant BNP Fragment in serum (n=4) is 100%.
The mean recovery of recombinant BNP Fragment in citrate plasma (n=8) is 108%.
線性
:
The mean dilution linearity of recombinant BNP Fragment in human serum samples
(n=7) is 118% for dilution factors 1+1 and 1+3.
交叉反應
:
The assay does not cross react with rat, mouse, dog, or cat samples.
參考範圍(健康人群)
:
Median (serum, n=76): 392 pmol/l.
推薦實驗室建立自己的參考值 。
本產品僅供科研使用